Literature DB >> 13316548

Neomycin in urinary tract infections; a clinical evaluation.

J D NIEBEL, M L ROSENBERG.   

Abstract

Neomycin was effective in treating 31 cases of severe Gram-negative bacillary urinary tract infections sensitive to neomycin and resistant to other agents. The recommended dosage schedule of 0.5 gm. every 12 hours for five days was demonstrated to be relatively safe. However, close watch should be maintained for signs of nephrotoxicity and ototoxicity.

Entities:  

Keywords:  NEOMYCIN/therapeutic use; URINARY TRACT/infections

Mesh：

Substances：

Year:  1956        PMID： 13316548      PMCID： PMC1531819     

Source DB:  PubMed          Journal:  Calif Med        ISSN： 0008-1264


  3 in total

1.  Sensitivity of various clinically important bacteria to four antibiotics; results obtained with a plate screening method.

Authors:  L A RANTZ; H H RANTZ
Journal:  Stanford Med Bull       Date:  1953-08

2.  Current therapeutics. LXVI. Neomycin.

Authors:  E J PULASKI
Journal:  Practitioner       Date:  1953-06

3.  Neomycin, a New Antibiotic Active against Streptomycin-Resistant Bacteria, including Tuberculosis Organisms.

Authors:  S A Waksman; H A Lechevalier
Journal:  Science       Date:  1949-03-25       Impact factor: 47.728
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.